LATEST NEWS

07.18.11

The Certificate of Incorporation for KRF was completed by three initial board members, Michael Tirgan, MD acting as the Medical Officer, Nadereh Nouhi acting as the Business Manager and Alexander Duggan acting as the Patient Advocate and Liaison.

07.18.11

First draft of three clinical trials have been completed and considered for implementation. St. Luke's Roosevelt Hospital Center's Institutional Review Board (IRB) was chosen to be the IRB for these three trials.

07.18.11

KRF has chosen Rockefeller University as a central laboratory to perform keloid tissue testing.